Agios Pharmaceuticals | ApexOnco - Clinical Trials news and analysis

x

“It's very intuitive and always up-to-date”

Head of Market Insights Oncology Europe

Daiichi Sankyo

Click here for more information

Data insights Regulatory

8 August 2024

The month ahead: August’s remaining events

Following its odronextamab knockback, Regeneron now faces a delay to linvoseltamab.

Subscribe to Agios Pharmaceuticals